Atlas Trials

Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis

Clinical trial NCT04794946 · UNKNOWN

Trial details

NCT number
NCT04794946
Sponsor
Institute of Liver and Biliary Sciences, India
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2021-03-19
Primary completion
2022-03-19
Enrollment
2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.